Lewis-Eng joins Venable
This article was originally published in The Tan Sheet
Former Emord & Associates principal Claudia Lewis-Eng signs on as partner at Washington, DC-based Venable Sept. 20. Lewis-Eng will be "another key member to [Venable's] growing food and drug practice," the firm says. Venable's "principal strengths run across both the FTC and FDA practices - no other firm, in my opinion, has the strength and depth of Venable's platform," according to Lewis-Eng. "I want to help build one of the country's premier dietary supplement practices," she adds. Lewis-Eng's current clients include Schiff Nutrition International, formerly Weider Nutrition International, and direct marketer AdvoCare...
You may also be interested in...
The termination of the Aurobindo-Sandoz deal isn’t perhaps all bad news for the Indian firm and the flip side may be an improved balance sheet, according to some analysts. But the resolution of compliance issues at manufacturing facilities remains critical.
“When COVID-19 hit, we really decided to accelerate plans,” says BlueWillow CEO Dave Peralta. NanoBio Protect contains OTC monograph ingredient benzalkonium chloride in a proprietary nanotechnology, alcohol-free formulation to help reduce germs on skin inside and around the nose that could cause infections.
Eschewing the standard approval mechanisms for COVID-19 vaccines is likely only appropriate in very limited high-risk populations, unless clinical efficacy outcomes are available, former FDA leaders say.